Get the Stockscreener App
3.16
11.27%
0.32
After Hours:
3.05
-0.11
-3.48%
CSPC Pharmaceutical Group Limited. ADR Stock (CSPCY) Forecast
The CSPC Pharmaceutical Group Limited. ADR (CSPCY) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.73, representing a +18.04% increase from the current price of $3.16. The highest analyst price target is $4.09, and the lowest is $3.37.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CSPCY Price Target
Average 4.36
(+37.97% Upside)
Long-term CSPCY price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about CSPC Pharmaceutical Group Limited. ADR financial reports and earnings history, CSPC Pharmaceutical Group Limited. ADR (CSPCY) stock could reach $4.09 by 2030, $4.40 by 2040 and $5.20 by 2050. See the projected annual prices until 2050 of the CSPC Pharmaceutical Group Limited. ADR stock below:
- CSPC Pharmaceutical Group Limited. ADR (CSPCY) is expected to reach an average price of $3.80 in 2035, with a high prediction of $4.17 and a low estimate of $3.75. This indicates an $20.25% rise from the last recorded price of $3.16.
- CSPC Pharmaceutical Group Limited. ADR (CSPCY) stock is projected to chart a bullish course in 2040, with an average price target of $4.0225, representing an $27.29% surge from its current level. The forecast ranges from a conservative $3.82 to a sky-high $4.40.
- Our analysts predict CSPC Pharmaceutical Group Limited. ADR (CSPCY) to jump 36.08% by 2045, soaring from $3.90 to an average price of $4.30, potentially reaching $4.50. While $3.90 is the low estimate, the potential upside is significant.
- CSPC Pharmaceutical Group Limited. ADR (CSPCY) stock is expected to climb by 2050, reaching an average of $4.31, a $36.39% jump from its current level. However, a wide range of estimates exists, with high and low targets of $5.20 and $4.12, respectively, highlighting the market's uncertainty.
CSPC Pharmaceutical Group Limited. ADR Stock (CSPCY) Year by Year Forecast
CSPC Pharmaceutical Group Limited. ADR Stock (CSPCY) Price Forecast for 2025
CSPC Pharmaceutical Group Limited. ADR Stock (CSPCY) is expected to reach an average price of $4.36 in 2025, with a high prediction of $5.35 and a low estimate of $3.37. This indicates an +37.97% rise from the last recorded price of $3.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $4.00 | $3.37 | $4.09 | +26.58% |
| July, 2025 | $4.80 | $3.93 | $5.04 | +51.90% |
| August, 2025 | $5.16 | $4.60 | $5.35 | +63.29% |
| September, 2025 | $4.27 | $3.90 | $4.8399 | +35.13% |
| October, 2025 | $4.0225 | $3.82 | $4.40 | +27.29% |
| November, 2025 | $3.49 | $3.37 | $4.15 | +10.44% |
| December, 2025 | $4.22 | $3.47 | $4.51 | +33.54% |
CSPC Pharmaceutical Group Limited. ADR Stock (CSPCY) Price Forecast for 2026
The predicted value for CSPC Pharmaceutical Group Limited. ADR (CSPCY) in 2026 is set at an average of $4.36. Estimates vary from a peak of $5.35 to a trough of $3.37, indicating an +37.97% surge from the present price of $3.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $5.095 | $3.93 | $5.35 | +61.23% |
| February, 2026 | $4.13 | $4.12 | $5.20 | +30.70% |
| March, 2026 | $3.90 | $3.85 | $4.50 | +23.42% |
| April, 2026 | $4.01 | $3.77 | $4.17 | +26.90% |
| May, 2026 | $3.84 | $3.37 | $4.09 | +21.52% |
| June, 2026 | $4.80 | $3.70 | $5.04 | +51.90% |
| July, 2026 | $5.16 | $4.60 | $5.35 | +63.29% |
| August, 2026 | $4.27 | $3.90 | $4.8399 | +35.13% |
| September, 2026 | $4.0225 | $3.82 | $4.40 | +27.29% |
| October, 2026 | $3.49 | $3.37 | $4.15 | +10.44% |
| November, 2026 | $4.22 | $3.47 | $4.51 | +33.54% |
| December, 2026 | $5.095 | $3.93 | $5.35 | +61.23% |
CSPC Pharmaceutical Group Limited. ADR Stock (CSPCY) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for CSPC Pharmaceutical Group Limited. ADR (CSPCY) is $4.36, with a high forecast of $5.35 and a low forecast of $3.37. This indicates an +37.97% increase from the last price of $3.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.13 | $4.12 | $5.20 | +30.70% |
| February, 2027 | $4.30 | $3.90 | $4.50 | +36.08% |
| March, 2027 | $4.01 | $3.77 | $4.35 | +26.90% |
| April, 2027 | $3.84 | $3.37 | $4.09 | +21.52% |
| May, 2027 | $4.80 | $3.70 | $5.04 | +51.90% |
| June, 2027 | $5.16 | $4.60 | $5.35 | +63.29% |
| July, 2027 | $4.31 | $4.0713 | $4.8399 | +36.39% |
| August, 2027 | $4.0225 | $3.82 | $4.40 | +27.29% |
| September, 2027 | $3.49 | $3.37 | $4.15 | +10.44% |
| October, 2027 | $4.29 | $3.47 | $4.35 | +35.76% |
| November, 2027 | $5.095 | $3.93 | $5.35 | +61.23% |
| December, 2027 | $4.13 | $4.12 | $5.20 | +30.70% |
CSPC Pharmaceutical Group Limited. ADR Stock (CSPCY) Price Forecast for 2028
In 2028, CSPC Pharmaceutical Group Limited. ADR (CSPCY) is projected to reach an average price of $4.36, with a high projection of $5.35 and a low estimate of $3.37. This indicates an +37.97% rise from the last price of $3.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.90 | $3.85 | $4.50 | +23.42% |
| February, 2028 | $4.01 | $3.77 | $4.17 | +26.90% |
| March, 2028 | $3.84 | $3.37 | $4.09 | +21.52% |
| April, 2028 | $4.07 | $3.70 | $4.51 | +28.80% |
| May, 2028 | $5.16 | $4.30 | $5.35 | +63.29% |
| June, 2028 | $4.31 | $4.0713 | $4.8399 | +36.39% |
| July, 2028 | $4.0225 | $3.82 | $4.40 | +27.29% |
| August, 2028 | $3.49 | $3.37 | $4.15 | +10.44% |
| September, 2028 | $4.29 | $3.47 | $4.35 | +35.76% |
| October, 2028 | $5.095 | $3.93 | $5.35 | +61.23% |
| November, 2028 | $4.13 | $4.12 | $5.20 | +30.70% |
| December, 2028 | $4.30 | $3.90 | $4.50 | +36.08% |
CSPC Pharmaceutical Group Limited. ADR Stock (CSPCY) Price Forecast for 2029
The 2029 price forecast for CSPC Pharmaceutical Group Limited. ADR Stock (CSPCY) is $4.36 on average, with a high prediction of $5.35 and a low estimate of $3.37. This represents an +37.97% increase from the previous price of $3.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.01 | $3.77 | $4.35 | +26.90% |
| February, 2029 | $3.84 | $3.37 | $4.09 | +21.52% |
| March, 2029 | $4.07 | $3.70 | $4.51 | +28.80% |
| April, 2029 | $5.16 | $4.30 | $5.35 | +63.29% |
| May, 2029 | $4.31 | $4.0713 | $4.8399 | +36.39% |
| June, 2029 | $4.025 | $3.83 | $4.40 | +27.37% |
| July, 2029 | $3.49 | $3.37 | $4.15 | +10.44% |
| August, 2029 | $4.29 | $3.47 | $4.35 | +35.76% |
| September, 2029 | $4.88 | $3.93 | $5.04 | +54.43% |
| October, 2029 | $4.13 | $4.12 | $5.35 | +30.70% |
| November, 2029 | $4.30 | $3.90 | $4.50 | +36.08% |
| December, 2029 | $4.01 | $3.77 | $4.35 | +26.90% |
CSPC Pharmaceutical Group Limited. ADR Stock (CSPCY) Price Forecast for 2030
CSPC Pharmaceutical Group Limited. ADR Stock (CSPCY) is expected to reach an average price of $4.36 in 2030, with a high forecast of $5.35 and a low forecast of $3.37. This signifies an +37.97% surge from the last price of $3.16.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.84 | $3.37 | $4.09 | +21.52% |
| February, 2030 | $4.07 | $3.70 | $4.51 | +28.80% |
| March, 2030 | $4.87 | $4.30 | $5.35 | +54.11% |
| April, 2030 | $4.31 | $4.0713 | $5.20 | +36.39% |
| May, 2030 | $4.025 | $3.83 | $4.40 | +27.37% |
| June, 2030 | $3.80 | $3.75 | $4.15 | +20.25% |
| July, 2030 | $4.29 | $3.37 | $4.35 | +35.76% |
| August, 2030 | $4.88 | $3.93 | $5.04 | +54.43% |
| September, 2030 | $4.13 | $4.12 | $5.35 | +30.70% |
| October, 2030 | $4.30 | $3.90 | $4.50 | +36.08% |
| November, 2030 | $3.93 | $3.82 | $4.35 | +24.37% |
| December, 2030 | $3.84 | $3.37 | $4.09 | +21.52% |
0.34%
3.19%
Cap:
|
Volume (24h):